These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 15181415

  • 1. [Use of protein C concentrate in adult patients with severe sepsis and septic shock].
    Baratto F, Michielan F, Gagliardi G, Di Gregorio G, Pasqualetto A, Meroni M, Giron GP.
    Minerva Anestesiol; 2004 May; 70(5):351-6. PubMed ID: 15181415
    [Abstract] [Full Text] [Related]

  • 2. Use of protein C concentrate in pediatric patients with sepsis.
    Silvani P, Camporesi A, Licari E, Wolfler A.
    Minerva Anestesiol; 2005 Jun; 71(6):373-8. PubMed ID: 15886604
    [Abstract] [Full Text] [Related]

  • 3. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
    Gullo A, Iscra F, Di Capua G, Berlot G, Lucangelo U, Peratoner A, Fasiolo S, Viviani M, Consales C, Zicari A.
    Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
    [Abstract] [Full Text] [Related]

  • 4. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
    de Kleijn ED, de Groot R, Hack CE, Mulder PG, Engl W, Moritz B, Joosten KF, Hazelzet JA.
    Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
    [Abstract] [Full Text] [Related]

  • 5. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
    Ettingshausen CE, Veldmann A, Beeg T, Schneider W, Jäger G, Kreuz W.
    Semin Thromb Hemost; 1999 Jun; 25(6):537-41. PubMed ID: 10632475
    [Abstract] [Full Text] [Related]

  • 6. Protein C concentrate as adjuvant treatment in neonates with sepsis-induced coagulopathy: a pilot study.
    Decembrino L, D'Angelo A, Manzato F, Solinas A, Tumminelli F, De Silvestri A, De Lazzari S, Padovani E, Magarotto M, Chiandetti L, Saia SO, Stronati M.
    Shock; 2010 Oct; 34(4):341-5. PubMed ID: 20823695
    [Abstract] [Full Text] [Related]

  • 7. [Use of protein C concentrate in critical conditions: clinical experience in pediatric patients with sepsis].
    Pettenazzo A, Malusa T.
    Minerva Anestesiol; 2004 May; 70(5):357-63. PubMed ID: 15181416
    [Abstract] [Full Text] [Related]

  • 8. [Coagulation tests in septic surgical patients].
    Oberhofer D, Kucisec-Tepes N, Skok J, Vucić N, Cala K.
    Acta Med Croatica; 2004 May; 58(5):389-94. PubMed ID: 15756805
    [Abstract] [Full Text] [Related]

  • 9. Protein C concentrate to restore physiological values in adult septic patients.
    Baratto F, Michielan F, Meroni M, Dal Palù A, Boscolo A, Ori C.
    Intensive Care Med; 2008 Sep; 34(9):1707-12. PubMed ID: 18458873
    [Abstract] [Full Text] [Related]

  • 10. Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin).
    Schellongowski P, Bauer E, Holzinger U, Staudinger T, Frass M, Laczika K, Locker GJ, Quehenberger P, Rabitsch W, Schenk P, Knöbl P.
    Vox Sang; 2006 May; 90(4):294-301. PubMed ID: 16635072
    [Abstract] [Full Text] [Related]

  • 11. [Protein C concentrate in the treatment of severe sepsis in the pediatric setting].
    Ramos Guerrero R, López Castilla JD, Atienza Fernández M, Bautista Paloma J, Ramos Guerrero AJ, Muñoz Sáez M, Carranza Conde M, Soult Rubio JA.
    Farm Hosp; 2003 May; 27(6):391-5. PubMed ID: 14974885
    [Abstract] [Full Text] [Related]

  • 12. Use of activated protein C in liver transplantation patients with septic shock.
    Rinaldi L, Marietta M, Mignini MA, Donno L, Busani S, Codeluppi M, Masetti M, Girardis M.
    Liver Transpl; 2008 Nov; 14(11):1598-602. PubMed ID: 18972572
    [Abstract] [Full Text] [Related]

  • 13. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F, de Cataldo F.
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [Abstract] [Full Text] [Related]

  • 14. Acute renal failure in patients with severe sepsis and septic shock--a significant independent risk factor for mortality: results from the German Prevalence Study.
    Oppert M, Engel C, Brunkhorst FM, Bogatsch H, Reinhart K, Frei U, Eckardt KU, Loeffler M, John S, German Competence Network Sepsis (Sepnet).
    Nephrol Dial Transplant; 2008 Mar; 23(3):904-9. PubMed ID: 18065435
    [Abstract] [Full Text] [Related]

  • 15. Levels of protein C activity and clinical factors in early phase of pediatric septic shock may be associated with the risk of death.
    Samransamruajkit R, Hiranrat T, Prapphal N, Sritippayawan S, Deerojanawong J, Poovorawan Y.
    Shock; 2007 Nov; 28(5):518-23. PubMed ID: 17589380
    [Abstract] [Full Text] [Related]

  • 16. The current management of septic shock.
    Russel JA.
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [Abstract] [Full Text] [Related]

  • 17. [Early changes in function of hypothalamic-pituitary-target gland axis in patients with severe sepsis and septic shock].
    Cui N, Liu DW, Wang H, Zeng ZP, Long Y, Chai WZ, Liu HZ, Wang XT.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jun; 19(6):332-5. PubMed ID: 17577436
    [Abstract] [Full Text] [Related]

  • 18. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.
    Nguyen HB, Corbett SW, Menes K, Cho T, Daugharthy J, Klein W, Wittlake WA.
    Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336
    [Abstract] [Full Text] [Related]

  • 19. Use of IgM and IgA-enriched immunoglobulins in the treatment of severe sepsis and septic shock. Clinical experience.
    Berlot G, Dimastromatteo G.
    Minerva Anestesiol; 2004 Oct; 70(10):739-43; 743-5. PubMed ID: 15516885
    [Abstract] [Full Text] [Related]

  • 20. Upregulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis.
    Lindstrom O, Kylanpaa L, Mentula P, Puolakkainen P, Kemppainen E, Haapiainen R, Fernandez JA, Griffin JH, Repo H, Petaja J.
    Crit Care; 2006 Feb; 10(1):R16. PubMed ID: 16420659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.